Hennebicq Sylviane, Blagosklonov Oxana, Eustache Florence, Papaxanthos Aline, Drouineaud Veronique, Guillemain Catherine, Mirallie Sophie, Delepine Beatrice, Rives Nathalie, Berthaut Isabelle, Frapsauce Cynthia, Guérin Jean-François, Benchaib Mehdi
a CECOS Rhône-Alpes Grenoble, Centre d'AMP - Hôpital Couple Enfants niveau 2 Grenoble , France.
b CECOS Franche-Comté Bourgogne Besançon, Hôpital J. Minjoz Besançon , France.
Syst Biol Reprod Med. 2018 Apr;64(2):130-137. doi: 10.1080/19396368.2017.1382608. Epub 2017 Oct 11.
The purpose of the present multicenter study was to investigate whether an artificial insemination with donor sperm (AID) procedure after intra-couple intracytoplasmic sperm injection (ICSI) failure offers a significant chance of pregnancy and to identify prognostic factors for pregnancy after an AID procedure. An eleven-year retrospective multicenter study was conducted among 13 Centre d'Etude et de Conservation des Oeufs et du Sperme (CECOS) centers. A total of 319 couples having undergone an AID procedure after intra-conjugal ICSI failure were included in this study; a total of 1,159 AID and 1,011 intra-conjugal ICSI cycles were performed. Among the prognostics parameters, the parity and the embryo quality could not be adequately addressed, therefore the parity was not included in the statistical analysis and the embryo quality has been presented as preliminary observations. The pregnancy rate per cycle was 12.0% (139/1,159) and the overall AID pregnancy rate per couple was 43.6% (139/319). Normal or oligoasthenoteratozoospermia (OAT) semen and women aged 34 years or above at the time of AID procedure obtained the lowest AID clinical pregnancy rate. Azoospermia or cryptozoospermia semen and women aged below 34 years obtained the highest AID clinical pregnancy rate. In conclusion, the transition to the AID procedure after intra-conjugal ICSI failure allows such couples to obtain a pregnancy, however after each ART failure AID transition should be proposed according to the woman's age and sperm characteristics.
AID: artificial insemination with donor sperm; ICSI: intracytoplasmic sperm injection; CECOS: Centre d'Etude et de Conservation des Oeufs et du Sperme; OAT: oligoasthenoteratozoospermia; IVF: in vitro fertilization; ART: artificial reproductive technology; β hCG: beta human chorionic gonadotrophin; SD: standard deviation; OR: Odds ratio.
本多中心研究的目的是调查夫妻间胞浆内单精子注射(ICSI)失败后采用供精人工授精(AID)程序是否有显著的妊娠机会,并确定AID程序后妊娠的预后因素。在13个卵子与精子研究与保存中心(CECOS)中心进行了一项为期11年的回顾性多中心研究。本研究共纳入319对夫妻,他们在夫妻间ICSI失败后接受了AID程序;共进行了1159个AID周期和1011个夫妻间ICSI周期。在预后参数中,产次和胚胎质量无法得到充分评估,因此产次未纳入统计分析,胚胎质量作为初步观察结果呈现。每个周期的妊娠率为12.0%(139/1159),每对夫妻的总体AID妊娠率为43.6%(139/319)。正常或少弱畸精子症(OAT)精液以及AID程序时年龄在34岁及以上的女性获得的AID临床妊娠率最低。无精子症或隐匿性无精子症精液以及年龄低于34岁的女性获得的AID临床妊娠率最高。总之,夫妻间ICSI失败后过渡到AID程序可使此类夫妻获得妊娠,然而每次辅助生殖技术失败后,应根据女性年龄和精子特征建议进行AID过渡。
AID:供精人工授精;ICSI:胞浆内单精子注射;CECOS:卵子与精子研究与保存中心;OAT:少弱畸精子症;IVF:体外受精;ART:辅助生殖技术;β-hCG:人绒毛膜促性腺激素β亚基;SD:标准差;OR:比值比